North America Whole Slide Imaging Market Research Report – Segmented By Product, Application, End-User & Country (The United States, Canada and Rest of North America) – Industry Analysis on Size, Share, Trends & Growth Forecast (2024 to 2029)

Updated On: June, 2024
ID: 12836
Pages: 110

North America Whole Slide Imaging Market Size (2024 to 2029)

The North American market size for whole slide imaging is expected to grow at a CAGR of 20.59% from 2024 to 2029 and be worth USD 768.30 million by 2029 from USD 301.28 million in 2024.

The growing use of whole slide imaging in drug discovery procedures, technological developments in whole slide imaging, and the increased popularity of virtual slides over physical slides are all driving the North American whole slide imaging market. In addition, the rising incidence of cancer is predicted to propel the total market forward. Many pharmaceutical and biotech businesses have made large expenditures in medication discovery due to increased research. As a result, imaging is currently used in all stages of drug development. As a result, imaging and image-based technologies are now widely used throughout drug development. They hold enormous promise for R&D by helping researchers better comprehend and work with model organisms.

With the advancement of digital pathology and computer-assisted artificial intelligence technology, it is unavoidable that digital health will play a key role in cancer research and precision medication delivery strategy. As a result, whole slide imaging devices are becoming more popular in cancer research and precision medicine, as many diseases may be diagnosed by looking at them under a microscope. The participation of pathologists in precision medicine and digital technologies is anticipated to be a crucial driver for better patient care.  With digital imaging technology, several pharmaceutical and biotech companies are making tremendous advances in drug discovery. As a result, digital imaging technologies are becoming more widely used in drug discovery processes and research and development, allowing scientists to study and work with a variety of model species. This would help standardize research, reduce costs while improving quality, and make it more manageable.

Furthermore, the increased demand for high-speed, high-resolution digital images in pathological laboratories and rapid innovation in digital imaging technologies are projected to drive the whole slide imaging market forward.

However, the high hardware cost for on-premise solutions prevents imaging scanners from being used in clinical settings where test samples are processed for a single diagnosis. This has also slowed the use of slide imaging scanners in small-scale labs, limiting the expansion of the whole slide imaging market in the APAC region. In addition, the high cost of purchasing and maintaining WSI systems is likely to restrict the growth of the entire slide imaging market. Still, the lack of established professional billing codes and imaging format standardization may hinder the market's expansion.

This research report on the North America whole slide imaging market has been segmented and sub-segmented into the following categories:

By Product:

  • Scanners
  • Viewers
  • Image management system
  • Software
  • Service
  • Hardware

By Application:

  • Telepathology
  • Cytopathology
  • Immunohistochemistry
  • Hematopathology
  • Cancer
  • Cardiology

By End-User:

  • Biotechnology and Pharmaceutical Companies
  • Academic and Research Institutes
  • Hospitals and Clinics

By Country:

  • The United States
  • Canada
  • Rest of North America

Due to the supportive government initiatives to deploy advanced technologies and expanding research and development activities, the market for whole slide imaging systems in North America is likely to grow at a healthy growth rate. Furthermore, the market for whole slide imaging systems in North America would increase due to the strong presence of prominent manufacturers in the region. With more than one-third of the market share, North America dominated the whole slide imaging market. The government's investment in healthcare infrastructure increased awareness of digital pathology, and strategic efforts by manufacturers are among the prominent drivers driving the market's rise in the region. Using whole slide imaging technology, long-term tissue investigation, 3D image reconstruction, thorough cell counting and analysis, and stereological analysis are all possible.

KEY MARKET PLAYERS:

Companies playing a key role in the North American whole slide imaging market profiled in this report are Philips, Siemens, Positron Corporation, Agfa-Gevaert N.V., CardiArc Ltd., Digirad Corporation, Gamma Medica Inc., GE Healthcare, Hologic Inc., Leica Microsystems GmbH, Nikon Corporation, Visiopharm, 3Dhistech, Hamamatsu Photonics KK, and Indica Labs.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1400

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample